WINDTREE THERAPEUTICS INC /DE/ Preferred Stock Dividends, Income Statement Impact
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Preferred Stock Dividends, Income Statement Impact of $1.72 million for the 3-month period ending 2018-12-31, per its 10-K filed 2020-04-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2020-04-03
- WINDTREE THERAPEUTICS INC /DE/ preferred stock dividends, income statement impact for the quarter ending 2018-12-31 was $1.72M.
- WINDTREE THERAPEUTICS INC /DE/ preferred stock dividends, income statement impact for the quarter ending 2017-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ preferred stock dividends, income statement impact for the quarter ending 2017-09-30 was $2.23M.
- WINDTREE THERAPEUTICS INC /DE/ preferred stock dividends, income statement impact for the quarter ending 2017-06-30 was $532.00K.
- WINDTREE THERAPEUTICS INC /DE/ preferred stock dividends, income statement impact for fiscal 2018 was $1.72M, a 73.03% decline from fiscal 2017.
- WINDTREE THERAPEUTICS INC /DE/ preferred stock dividends, income statement impact for fiscal 2017 was $6.37M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 3 month as first filed | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 9 month as first filed | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $1.72M 10-K · filed 2020-04-03 | $1.72M 10-K · filed 2020-04-03 | ||||
| 2017-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | $2.23M derived: sum of 2 quarters · filed 2019-04-23 | $2.77M derived: sum of 3 quarters · filed 2019-04-23 | $6.37M 10-K/A · filed 2019-04-23 | ||
| 2017-09-30 | $2.23M 10-K/A · filed 2019-04-23 | $1.92M 10-Q · filed 2017-11-14 | $2.77M derived: sum of 2 quarters · filed 2019-04-23 | $6.37M 10-Q · filed 2018-11-14 | $6.05M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $532.00K 10-K/A · filed 2019-04-23 | $4.14M 10-Q · filed 2018-08-14 | ||||
| 2017-03-31 | $3.60M 10-K · filed 2020-04-03 | $3.60M 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |